NICE hypertension in pregnancy recommendations | P-valuea | P-valueb (CI) | ||
---|---|---|---|---|
Before guidance N = 1271 | After guidance N = 1219 | |||
High risk of pre-eclampsia | 73 (6) | 93 (8) | 0.06 | 0.05 (−0.01, 0.04) |
Moderate risk of pre-eclampsia | 105 (9) | 116 (10) | 0.20 | 0.40 (−0.03, 0.01) |
N = 73 | N = 93 | |||
Aspirin prescription for high risk women | 10 (14) | 50 (54) | < 0.01 | < 0.01 (0.37, 0.43) |
N = 105 | N = 116 | |||
Aspirin prescription for moderate risk women | 3 (3) | 63 (54) | < 0.01 | < 0.01 (0.48, 0.54) |
Management of pre-existing hypertension | N = 1271 | N = 1219 | ||
Diagnosis of pre-existing hypertension | 17 (1) | 41 (3) | < 0.01 | < 0.01 (0.01, 0.03) |
ACE or ARBs used prior to or in early pregnancy | 2 (12) | 10 (25) | 0.30 | 0.27 (−0.07, 0.34) |
N = 2 | N = 10 | |||
Alternatives to ACE or ARBs prescribed | 2 (100) | 8 (80) | 0.50 | 0.05 (−0.45, − 0.08) |